Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Holly Posner
Eisai Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Arkansas Research (care)
Hot Springs, Arkansas, United States
- Comprehensive Neuroscience
St. Petersburg, Florida, United States
- St. Francis Medical Center
Peoria, Illinois, United States
- Neurological Associate of Albany Pc
Albany, New York, United States
- University of Texas Mental Sciences Institute
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2003
- Primary completion
- 31 Aug 2005
- Completion
- 30 Jun 2006
- Last update posted
- 1 Apr 2011
- Registered enrollment
- 974
- Registry id
- NCT00165737
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.